acebutolol and Anemia, Cooley's

acebutolol has been researched along with Anemia, Cooley's in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altermatt, P; Doucerain, C; Dürrenberger, F; Flace, A; Manolova, V; Nyffenegger, N; Sundstrom, H; Varol, A	1

Other Studies

1 other study(ies) available for acebutolol and Anemia, Cooley's

Article	Year
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia. The Journal of clinical investigation, 2019, 12-09, Volume: 130, Issue:1 Topics: Administration, Oral; Animals; beta-Globins; beta-Thalassemia; Cation Transport Proteins; Cell Line; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Erythropoiesis; Female; Ferric Compounds; Hepcidins; Humans; Iron; Madin Darby Canine Kidney Cells; Male; Maltose; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Proteolysis; Rats, Sprague-Dawley; Ubiquitination	2019

Article

Year

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.

The Journal of clinical investigation, 2019, 12-09, Volume: 130, Issue:1

Topics: Administration, Oral; Animals; beta-Globins; beta-Thalassemia; Cation Transport Proteins; Cell Line; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Erythropoiesis; Female; Ferric Compounds; Hepcidins; Humans; Iron; Madin Darby Canine Kidney Cells; Male; Maltose; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Proteolysis; Rats, Sprague-Dawley; Ubiquitination

2019